<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7321236\results\search\testTrace\results.xml">
  <result pre="be more useful for infected patients with diabetes, while anti-coagulant" exact="treatment" post="is proposed in severe SARS-CoV-2 induced pneumonia. coronavirus SARS-CoV-2"/>
  <result pre="developed for other purposes that have been proposed for the" exact="treatment" post="of SARS-CoV-2 and are under clinical trials, most are"/>
  <result pre="APN01 [8]. Lopinavir and ritonavir designed and approved for the" exact="treatment" post="of AIDS were the first protease inhibitors used for"/>
  <result pre="of AIDS were the first protease inhibitors used for the" exact="treatment" post="of SARS-CoV-2 [5,6]. Both drugs were proposed as promising"/>
  <result pre="[5,6]. Both drugs were proposed as promising agents for the" exact="treatment" post="of SARS-CoV-1 by an in silico study conducted in"/>
  <result pre="anti-viral agents are ribavirin, a nucleoside analogue used for the" exact="treatment" post="of Lassa fever virus, influenza A and B and"/>
  <result pre="and HCV [12]; telbivudine, a nucleoside analogue used for the" exact="treatment" post="of HAV [12]; the HIV-1 integrase inhibitors raltegravir and"/>
  <result pre="drug targets for anti-viral therapy as well as for the" exact="treatment" post="of various diseases. There is a number of approved"/>
  <result pre="inhibitors, with more than twenty compounds with applications in the" exact="treatment" post="of hypertension; thrombin as well as coagulation Factor Xa"/>
  <result pre="as anti-thrombotic agents. DPP-4 inhibitors, gliptins, are used for the" exact="treatment" post="of type II diabetes, with seventeen drugs of this"/>
  <result pre="were selected because they have already been proposed for the" exact="treatment" post="of SARS-CoV-2. The rest of the drugs that were"/>
  <result pre="melagatran of Î±-thrombin inhibitors. The DPP-4 inhibitors developed for the" exact="treatment" post="of diabetes type II as well as the Î±-thrombin"/>
  <result pre="with non SARS-CoV-2-induced pneumonia. Furthermore, according to recent results, anti-coagulant" exact="treatment" post="by heparin administration reduced mortality of COVID-19 patients with"/>
  <result pre="in vivo anti-viral activity. The DPP-4 inhibitors developed for the" exact="treatment" post="of type II diabetes, as well as Î±-thrombin and"/>
  <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov.20206162010.1038/s41421-020-0156-032194981 8.UBC, Apeiron Biologics to Trial Coronavirus"/>
  <result pre="M protease from clinically approved medicinesJ. Genet. Genom.20204711912110.1016/j.jgg.2020.02.001 11.JoshiT.JoshiT.SharmaP.MathpalS.PundirH.BhattV.ChandraS.In silico" exact="screening" post="of natural compounds against COVID-19 by targeting Mpro and"/>
  <result pre="and ACE2 using molecular dockingEur. Rev. Med. Pharmacol. Sci.2020244529453610.26355/eurrev_202004_2103632373991 12.KandeelM.Al-NazawiM.Virtual" exact="screening" post="and repurposing of FDA approved drugs against COVID-19 main"/>
  <result pre="18.GyebiG.A.OgunroO.B.AdegunloyeA.P.OgunyemiO.M.AfolabiS.O.Potential Inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico" exact="screening" post="of Alkaloids and Terpenoids from African medicinal plantsJ. Biomol."/>
  <result pre="Biomol. Struct. Dyn.2020511910.1080/07391102.2020.176486832367767 19.TsujiM.Potential anti-SARS-CoV-2 drug candidates identified through virtual" exact="screening" post="of the ChEMBL database for compounds that target the"/>
  <result pre="Cleavage AssayPLoS ONE20127e3575910.1371/journal.pone.003575922558217 25.LankasG.R.LeitingB.RoyR.S.EiermannG.J.BeconiM.G.BiftuT.ChanC.C.EdmondsonS.FeeneyW.P.HeH.et al.Dipeptidyl peptidase IV inhibition for the" exact="treatment" post="of type 2 diabetes: Potential importance of selectivity over"/>
  <result pre="ChEMBL1779710 Approved 2015 Dong-A ST Headache, nasopharyngitis, upper respiratory tract" exact="infection" post="[47] Gemigliptin - Approved 2011 LG Life Sciences Generally"/>
  <result pre="&amp;amp; Co. Headache, swelling of the legs, upper respiratory tract" exact="infection" post="[51] Teneligliptin - Approved in Japan 2012 Mitsubishi Tanabe"/>
 </snippets>
</snippetsTree>
